Eric Bjerkholt
CHIEF FINANCIAL OFFICER; Director · 3 filings · Latest: Jun 2, 2026
CERUS CORP
Mirum Pharmaceuticals, Inc.
Surrozen, Inc./DE
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
CERS | Eric Bjerkholt | Director | Jun 2, 2026 | Grant/Award | $0.00 | 60,000 | — | 282,133 | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Mar 16, 2026 | Sale | $91.98 | 7,287 | $670.2K | 49,788 | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Mar 15, 2026 | Option Exercise | — | 13,334 | — | 57,075 |